Back
Anika Therapeutics 10K Form
Sell
49
ANIK
Anika Therapeutics
Last Price:
26.47
Seasonality Move:
7.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-03 | 10Q | ANIK/Anika Therapeutics Quarterly |
| 2023-08-08 | 10Q | ANIK/Anika Therapeutics Quarterly |
| 2023-05-09 | 10Q | ANIK/Anika Therapeutics Quarterly |
| 2022-11-09 | 10Q | ANIK/Anika Therapeutics Quarterly |
| 2022-08-04 | 10Q | ANIK/Anika Therapeutics Quarterly |
| 2022-05-06 | 10Q | ANIK/Anika Therapeutics Quarterly |
Receive ANIK News And Ratings
See the #1 stock for the next 7 days that we like better than ANIK
ANIK Financial Statistics
Sales & Book Value
| Annual Sales: | $166.66M |
|---|---|
| Cash Flow: | $1.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $14.48 |
| Price / Book: | 1.81 |
Profitability
| EPS (TTM): | -5.65000 |
|---|---|
| Net Income (TTM): | $-82.67M |
| Gross Margin: | $103.09M |
| Return on Equity: | -31.32% |
| Return on Assets: | -25.58% |
Anika Therapeutics Earnings Forecast
Key Anika Therapeutics Financial Ratios
- The Gross Profit Margin over the past 31 years for ANIK is 61.85%.
- The Selling, General & Administrative Expenses for ANIK have been equal to 57.51% of Gross Profit Margin.
- The Research & Development expenses have been 19.61% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of ANIK is -49.60% of Total Revenues.
- Per Share Earnings over the last 31 years have been positive in 15 years.
Anika Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ANIK |
| CUSIP: | 035255 |
| Website: | anika.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.26 |
| Quick Ratio: | 3.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 30.32 |
ANIK Technical Analysis vs Fundamental Analysis
Sell
49
Anika Therapeutics (ANIK)
is a Sell
Is Anika Therapeutics a Buy or a Sell?
-
Anika Therapeutics stock is rated a Sell
The current Anika Therapeutics [ANIK] share price is $25.97. The Score for ANIK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.